Liraglutide vs semaglutide

Saxenda vs Ozempic

Saxenda (liraglutide) was an earlier GLP-1 receptor agonist; Ozempic (semaglutide) is a newer, longer-acting one. The headline differences are dosing frequency (daily vs weekly) and the size of the average weight effect.

Both work through the GLP-1 pathway, but the newer molecule is more convenient and tends to produce more weight loss.

Educational only. This is educational, not medical advice. Everyone's body responds differently. Talk to your clinician before starting, stopping, changing, or tapering any medication, and work with your physician and a registered dietitian to personalize your approach.

At a glance

SaxendaOzempic
Active drugLiraglutideSemaglutide
DosingOnce daily injectionOnce weekly injection
Approved forWeight managementType 2 diabetes (weight off-label)
Avg. weight lossHigh single digits %Mid-teens % (at weight doses)
Regain after stopping (meta-analysis)Smallest absolute (~1.5 kg)Larger (more loss to regain)

Convenience and efficacy

Saxenda requires a daily injection; the newer once-weekly drugs are easier to sustain. Semaglutide also produces more average weight loss at weight-management doses.

That said, the right choice depends on tolerance, coverage, and your clinician's judgment, not convenience alone.

Which for whom

  • Some people tolerate one molecule better than another, or have coverage for one and not the other.
  • Daily vs weekly dosing is a real lifestyle factor.
  • The choice is a clinical one made with your prescriber.
The off-ramp angle

Which holds weight better after you stop?

In the regain meta-analysis, liraglutide showed the smallest absolute rebound, largely because its on-treatment loss is smaller, so there is less to regain. Semaglutide's larger loss can mean a larger rebound.

Either way, the maintenance principles are identical: the loss you keep depends on your habits, not the molecule.

FAQ

Frequently asked questions

Is Ozempic better than Saxenda?

Semaglutide (Ozempic) is once-weekly and tends to produce more weight loss than daily liraglutide (Saxenda). 'Better' still depends on your tolerance, coverage, and clinician's judgment.

Sources & further reading

Every claim on this page is drawn from peer-reviewed research, clinical trials, or recognized health authorities. Read the source before making any decision about your health.

  1. [1]Rebound or Retention: A Meta-Analysis of Weight Regain After Discontinuation of GLP-1 Receptor AgonistsNIH/PMC
  2. [2]Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regressionNIH/PMC

The drugs

Related guides